ADHD Treatment Market trends and Growth Opportunities | Key Market Players Janssen Pharma, Takeda, Sunovion, Tris Pharma
The Attention Deficit Hyperactivity Disorder Treatment Market was valued at around US$15 billion at the end of 2018. The revenue is said to engross over US$24 billion by 2026, with a CAGR of 6.1%. ADHD, classified under the diagnostic criteria DSM-5 by the American Psychiatric Association (APA), characterized by patterns of hyperactivity, inattentions, and impulsivity. […]